About Cellavision
Cellavision is a company based in Lund (Sweden) founded in 1994. The company has 236 employees. Cellavision has completed 1 acquisition, including RAL Diagnostics. Cellavision offers products and services including CellaVision® DM9600, CellaVision® Software, and CellaVision® Reagents. Cellavision operates in a competitive market with competitors including Diatron, MicroX Labs, LabNow, Livo and Drew Scientific, among others.
- Headquarter Lund, Sweden
- Employees 236
- Stage Public
- SectorsHealthcare
- Website cellavision.com
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Cellavision Ab
- Annual Revenue$82.41 M (USD)4.94as on Dec 31, 2025
- Net Profit$16.62 M (USD)8.78as on Dec 31, 2025
- EBITDA$26.21 M (USD)10.38as on Dec 31, 2025
- Latest Funding Round$12.47M (USD), Debt – Conventional
Sep 2019
- Investors
- Employee Count236
- Investments & Acquisitions
Products & Services of Cellavision
Cellavision offers a comprehensive portfolio of products and services, including CellaVision® DM9600, CellaVision® Software, and CellaVision® Reagents.
Device for automated digital microscopy of blood samples
Tools for remote review and analysis of lab samples
Reagents for hematology testing and sample preparation
Apps and channels of Cellavision
Cellavision publishes 1 mobile app with over 100K+ downloads; its YouTube channel CellaVision has 9.1K subscribers and 30 videos.
Videos from Cellavision
The most watched videos on Cellavision's YouTube channel, CellaVision (9.1K subscribers). Click a video to play it here.
More on CellaVision.
Funding Insights of Cellavision
- Total Rounds 1
- Last Round Debt – Conventional — $12.47M
- First Round $12.47M
(Sep 2019)
- Investors Count 1
All 1 funding rounds of Cellavision with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2019 | $12.47M | Debt – Conventional | – | – |
1 investors in total: 1 institutional.
Investors in Cellavision
Cellavision has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SEB.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
SEB is recognized as a leading Nordic corporate bank. | 1856 | sebgroup.com | Stockholm, Sweden |
Investor details for Cellavision
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cellavision
68 people are tracked at Cellavision (14 in leadership, 6 in board & advisors, 48 in team); the tracked headcount is 236.
| Name | Role | Group |
|---|---|---|
Gunnar B. Hansen | Director, Product Care | Leadership |
Andrew Gill | Director, Marketing | Leadership |
Martin Almers | Director, Innovation | Leadership |
Liude Zhang | Market Support Director, Greater China | Leadership |
Koichi Matsumoto | Representative Director, Japan | Leadership |
Zlatko Rihter | CEO | Leadership |
Adam Morell | VP, Engineering | Leadership |
Peter Wilson | VP, Global Marketing | Leadership |
Maria Morin | VP, Human Resources | Leadership |
Jan Nilsson | Director, Hardware | Leadership |
Magnus Johnsson | VP, Quality | Leadership |
Scott Dunbar | Director, Americas | Leadership |
Per Sennmalm | Director, Software & Applications | Leadership |
Charlotte Oom | Director, Quality | Leadership |
Christer Fåhraeus | Founder & Board Member | Board & advisors |
Jurgen Riedl | Director | Board & advisors |
Sören Mellstig | Chairman | Board & advisors |
Åsa Hedin | Director | Board & advisors |
Anna Malm Bernsten | Director | Board & advisors |
Stefan Wolf | Director | Board & advisors |
48 more people are available in the full profile.
Complete people profiles for Cellavision
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Cellavision
Cellavision is a publicly listed company on the OMXSTO with ticker symbol CEVI in Sweden, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date28 May 2007
- Listed onAKT: CEVI
- Listed entityCellaVision AB
- Exchange sectorHealth technology
- ISINSE0000683484
- Share price163.20 SEK (+0.87% on the day) · 2026-10-12
- Market capitalisation3,859,180,725.00 SEK
- Price to earnings30.2
- EPS (diluted, trailing year)5.41 SEK
- Dividend yield1.7%
- Volume (last session)6,111
Financials of Cellavision
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 759.0M SEK | 153.1M SEK | 241.4M SEK |
| 2024 | 723.2M SEK | 140.7M SEK | 218.7M SEK |
| 2023 | 677.3M SEK | 130.3M SEK | 206.8M SEK |
| 2022 | 639.3M SEK | 118.3M SEK | 201.7M SEK |
| 2021 | 565.5M SEK | 125.3M SEK | 196.2M SEK |
Detailed financial statements for Cellavision
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cellavision
Cellavision has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include RAL Diagnostics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Stains & Instruments for microscopy | ral-diagnostics.fr | Bordeaux, France | 1916 | Sep 2019 | $27.85M |
Complete acquisition details for Cellavision
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cellavision
4 dated milestones of Cellavision across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Cellavision is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $12.5M.
- Acquisition Acquires RAL Diagnostics.
Competitors of Cellavision
Cellavision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Diatron, MicroX Labs, LabNow, Livo and Drew Scientific, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| diatron.com | 1989 | Budapest, Hungary | – | 15 | Hematology and clinical chemistry analyzers with reagents are manufactured. | |
| microxlabs.com | 2013 | Bengaluru, India | $63,446 | – | MEMS-based biochips are developed for blood cell counting. | |
| labnow.com | 2005 | Austin, United States | $21.64M | – | Offers WBC counting point-of-care diagnostic systems for healthcare needs. | |
| livo.ai | 2018 | Hyderabad, India | $745,999 | – | Next-generation pathology laboratory equipment is manufactured and supplied. | |
| drew-scientific.com | 1980 | Miami, United States | – | – | Analytical Instruments for Clinical and Veterinary Hematology and HbA1c |
Detailed competitors of Cellavision
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cellavision
The website of Cellavision (cellavision.com) receives about 32.4K visits a month.
- Monthly visits32.4K
▼ 5.7% vs previous month
Websites whose visitors overlap most with Cellavision. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cellatlas.com | cellatlas.com | 100% | – | – | – |
cellavision-proficiency-software.com | cellavision-proficiency-software.com | 94% | – | #9,547,550 | – |
hematologyatlas.com | hematologyatlas.com | 75% | – | – | – |
rinshoudenken.gr.jp | rinshoudenken.gr.jp | 60% | – | – | – |
imagebank.hematology.org | imagebank.hematology.org | 60% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Cellavision
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Cellavision
Complete news archive for Cellavision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Cellavision
10 companies that operate in the same segment as Cellavision (Hematology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small activating RNA therapeutics are developed to restore gene function. | 2008 | London, England, United Kingdom | USD 460.41 M | USD 23.07 M | 37 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 442 M | – | 66 | |
Developer of therapeutics for the treatment of hematologic diseases | 2017 | Cambridge, Massachusetts, United States | USD 140 M | – | 84 | |
Gene therapy platform is developed for chronic disease treatments. | 2015 | Stevenage, Hertfordshire, United Kingdom | USD 273.69 M | USD 435.87 K | 152 | |
Novel anticoagulants for thrombosis treatment are developed. | 2019 | Cambridge, Massachusetts, United States | USD 250 M | – | 14 | |
Developer of therapies for treating hemochromatosis & beta thalassemia | 1989 | San Diego, California, United States | – | USD 75.72 M | 71 | |
Breakthrough therapies are developed for blood diseases and infections. | 2014 | Buffalo, New York, United States | USD 1 M | – | 22 | |
Hematology products and solutions are provided for medical applications. | 1971 | Braintree, Massachusetts, United States | – | USD 1.33 B | 3,020 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cellavision
Cellavision was founded in 1994 and raised its 1st funding round 25 years after it was founded.
Cellavision is headquartered in Lund, Sweden.
Cellavision has 236 employees.
Annual revenue of Cellavision is $82.41M as on Dec 31, 2025.
Cellavision develops and markets solutions for digital microscopy. Its proprietary platforms improve manual microscopy through automatic analyzers that use a combination if digital imaging, artificial intelligence and IT support. The company specializes in hematology and has analytic solutions for the differential diagnoses for peripheral blood smears, advanced RBC analyses and other body fluid smears.
Cellavision's top competitors include MicroX Labs, Diatron and Livo.
Cellavision offers CellaVision® DM9600, CellaVision® Software, and CellaVision® Reagents.
Yes, Cellavision is publicly traded on OMXSTO under the ticker symbol CEVI.
Cellavision has made 1 acquisition, including RAL Diagnostics.
Cellavision has 1 investor. Key investors include SEB.
Cellavision operates through Cellavision Inc.
Yes. Cellavision publishes CellaVision CellAtlas, with over 100,000 downloads.